Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 81 results

Search by release date:: Jan, 2023 ～ Dec, 2023

December 22, 2023
Otsuka Pharmaceutical

Otsuka Obtains the Additional Indication of Adjunctive Treatment of Major Depressive Disorder for Rexulti® in Japan
December 19, 2023
Otsuka Pharmaceutical

Otsuka and Ionis Enter into Licensing Agreement Covering Europe for Donidalorsen in Hereditary Angioedema
December 14, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Introduces New "Self-Care Leave" System
December 13, 2023
Otsuka Pharmaceutical

D&I Award 2023 - Otsuka Pharmaceutical Designated as "Best Workplace"
December 13, 2023
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory relaunches HINORAⓇ medicated toothpaste (quasi-drug) and HINORAⓇ Moisture Gel (oral cosmetic)
December 8, 2023
Otsuka Foods

Otsuka Foods to Launch New My Size Plus Support Series Making Nutritional Information Clear and Simple to Help Maintain Wellness Through Everyday Eating Available at Drugstores, Pharmacies and Other Outlets Nationwide Starting January 16, 2024
December 1, 2023
Otsuka Pharmaceutical

Pharmavite, a U.S. subsidiary of Otsuka Pharmaceutical, acquires Bonafide Health, a provider of women's health products
November 30, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Sponsor Thematic Project "Resonance of Lives" at the Expo 2025 Osaka, Kansai, Japan
November 22, 2023
Otsuka Pharmaceutical

Otsuka’s U.K. subsidiary Astex Has Third Approval Success in a Drug Discovery Collaboration 　　-AstraZeneca's Truqap for the treatment of metastatic breast cancer approved in the U.S.
November 10, 2023
Otsuka Pharmaceutical

Otsuka Submits New Drug Application in Japan for Voclosporin in the Treatment of Patients with Lupus Nephritis
November 8, 2023
Otsuka Pharmaceutical

MIREVO®, a New Cognitive Function Testing Application for Dementia Care Support, Obtains Regulatory Approval, a First in Japan
November 8, 2023
Otsuka Pharmaceutical

Selected as METI’s "Model Project for the Promotion of PHR Services"Launch of a Healthcare Service that Improves Health without Conscious Effort
November 8, 2023
Otsuka Medical Devices

Otsuka Medical Devices and Recor Medical Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.
November 7, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Granted Silver Certification in PRIDE Index 2023 for LGBTQ+ Initiatives
November 6, 2023
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory Announces Personnel Changes
November 6, 2023
Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory

Otsuka Announces Personnel Changes
November 6, 2023
Otsuka Pharmaceutical

New England Journal of Medicine Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab in Treatment of Immunoglobulin A Nephropathy (IgAN)
October 31, 2023
Otsuka Pharmaceutical

Otsuka Applies in Japan for the Additional Indication for Agitation Associated with Dementia due to Alzheimer's Disease for Rexulti® (brexpiprazole)
October 30, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Receives Eruboshi Grade 3 Certification as an Excellent Company Under the Act on Promotion of Women's Participation and Advancement in the Workplace
October 27, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
October 20, 2023
Otsuka Pharmaceutical

First PET Bottle and Paper Cup Recycling Initiatives for Tokyo Legacy Half Marathon
October 3, 2023
Otsuka Pharmaceutical

Introducing InnerSignal SC Rich Cream- Regulates moisture in the stratum corneum for a higher level of skin care experience -
September 19, 2023
Otsuka Pharmaceutical

Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
September 15, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Cooperative Agreement with Japan Association of Public Mental Health & Welfare Workers
September 14, 2023
Otsuka Foods

Otsuka Foods to Launch MATCH Vitamin Mikan 500ml PET Bottle New MATCH Carbonated Vitamin Drink Flavor Available Starting October 2
September 13, 2023
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches "Tumguide LED Light Source" and "Tumguide Fiber" as medical devices that configure "Tumguide," a device for checking the position of the nasogastric tube tip
September 8, 2023
Otsuka Pharmaceutical

Otsuka collaborates with Shape to develop novel AAV gene therapies for ocular diseases
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Lundbeck Announce Topline Results from Two Phase 3 Trials of Brexpiprazole as Combination Therapy
September 1, 2023
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Mindset Pharma - Strengthens pipeline in the area of psychiatric and neurological disorders -
August 30, 2023
Taiho Pharmaceutical

Taiho Pharmaceutical Announces the Launch of FGFR Inhibitor LYTGOBI® Tablets 4mg in Japan